Top Institutional Investors

FARALLON CAPITAL MANAGEMENT, L.L.C. — 13F Holdings & Portfolio

CIK 909661 · latest 13F-HR filed 2026-08-14

Backtest portfolio

FARALLON CAPITAL MANAGEMENT, L.L.C. manages $21.68B in 13F-reported U.S. long-equity assets across 89 reported positions as of its 2026-06-30 13F-HR filing. Its largest disclosed positions are SPY (20.67%), RVMD (11.71%), EA (7.49%). Quarter over quarter (versus its 2026-03-31 filing) the fund opened 21 new positions and exited 104; 36 existing positions rose in reported value and 24 fell.

AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.

Loading holdings…
AUM
$21.68B

Long-equity book

Holdings
89

Distinct positions

Period
2026-06-30

Filed 2026-08-14

Q/Q Activity
+21 / −104 / ↑36 / ↓24

vs 2026-03-31

Portfolio charts

Latest quarter's book, what changed, and how the portfolio has evolved across filings.

Firm Profile & Key People
Name Title / Status Ownership Type

Quarter-over-quarter changes

Changes in reported position value vs the prior 13F, so price moves count too, not just shares bought or sold.

Top Adds (vs prior quarter)

Show all 36 →

Top Trims

Show all 24 →

New Positions

Show all 21 →

Exited Positions

Show all 104 →

FARALLON CAPITAL MANAGEMENT, L.L.C. Holdings (2026-06-30)

Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).

# Issuer Symbol CUSIP Value Weight Shares Type
1 STATE STR SPDR S&P 500 ETF T Put SPY 78462F103 $4.48B 20.67% 6,000,000 SH
2 REVOLUTION MEDICINES INC RVMD 76155X100 $2.54B 11.71% 13,550,796 SH
3 ELECTRONIC ARTS INC EA 285512109 $1.62B 7.49% 7,919,500 SH
4 BRIDGEBIO PHARMA INC BBIO 10806X102 $800.1M 3.69% 10,743,063 SH
5 PROTAGONIST THERAPEUTICS INC PTGX 74366E102 $778.2M 3.59% 6,348,906 SH
6 EXELIXIS INC EXEL 30161Q104 $732.8M 3.38% 13,468,010 SH
7 LIQUIDIA CORPORATION LQDA 53635D202 $666.9M 3.08% 8,365,038 SH
8 AMAZON COM INC AMZN 023135106 $627.5M 2.90% 2,632,994 SH
9 LANTHEUS HLDGS INC LNTH 516544103 $619.4M 2.86% 5,583,479 SH
10 NATERA INC NTRA 632307104 $602.2M 2.78% 2,218,366 SH
11 UNITEDHEALTH GROUP INC UNH 91324P102 $528.1M 2.44% 1,270,532 SH
12 THERMO FISHER SCIENTIFIC INC TMO 883556102 $526.0M 2.43% 1,049,185 SH
13 ROIVANT SCIENCES LTD ROIV G76279101 $506.4M 2.34% 14,309,000 SH
14 AON PLC AON G0403H108 $458.6M 2.12% 1,382,562 SH
15 BOSTON SCIENTIFIC CORP BSX 101137107 $449.0M 2.07% 10,521,184 SH
16 BROADCOM INC AVGO 11135F101 $435.1M 2.01% 1,151,800 SH
17 MICROSOFT CORP MSFT 594918104 $415.1M 1.92% 1,112,863 SH
18 TANGO THERAPEUTICS INC TNGX 87583X109 $383.8M 1.77% 12,277,000 SH
19 KKR & CO INC KKR 48251W104 $378.0M 1.74% 4,118,300 SH
20 SYNOPSYS INC SNPS 871607107 $370.1M 1.71% 829,600 SH
21 BEAM THERAPEUTICS INC BEAM 07373V105 $351.3M 1.62% 10,236,396 SH
22 CRINETICS PHARMACEUTICALS IN CRNX 22663K107 $336.4M 1.55% 8,989,098 SH
23 GRAIL INC GRAL 384747101 $284.1M 1.31% 4,161,584 SH
24 WABTEC WAB 929740108 $241.2M 1.11% 894,503 SH
25 IMMUNOVANT INC IMVT 45258J102 $223.7M 1.03% 5,805,000 SH
26 TWIST BIOSCIENCE CORP TWST 90184D100 $219.8M 1.01% 2,136,400 SH
27 AGIOS PHARMACEUTICALS INC AGIO 00847X104 $219.6M 1.01% 5,917,400 SH
28 ARAMARK ARMK 03852U106 $206.3M 0.95% 3,625,731 SH
29 BAIDU INC BIDU 056752108 $137.6M 0.63% 1,203,785 SH
30 NOVO-NORDISK A S NVO 670100205 $125.6M 0.58% 2,619,000 SH
31 ACADIA HEALTHCARE COMPANY IN ACHC 00404A109 $124.6M 0.58% 4,220,800 SH
32 BRIGHTSPRING HEALTH SVCS INC BTSG 10950A106 $120.8M 0.56% 1,732,800 SH
33 ASTRAZENECA PLC AZN G0593M107 $108.8M 0.50% 574,000 SH
34 JOHNSON & JOHNSON JNJ 478160104 $103.6M 0.48% 408,000 SH
35 ISHARES TR Put SOXX 464287523 $83.3M 0.38% 130,000 SH
36 STRATEGY INC MHIFF 594972AS0 $75.4M 0.35% 87,858,000 PRN
37 PARABILIS MEDICINES INC PBLS 698955101 $64.8M 0.30% 2,368,200 SH
38 NOVARTIS AG NVS 66987V109 $56.9M 0.26% 363,000 SH
39 GUARDANT HEALTH INC GH 40131M109 $48.3M 0.22% 322,200 SH
40 VNET GROUP INC VNET 90138AAE3 $46.8M 0.22% 45,000,000 PRN
41 AVALO THERAPEUTICS INC AVTX 05338F306 $46.2M 0.21% 2,498,000 SH
42 JOYY INC JOYY 46591M109 $46.1M 0.21% 699,200 SH
43 ASSEMBLY BIOSCIENCES INC ASMB 045396207 $44.1M 0.20% 1,604,590 SH
44 ENANTA PHARMACEUTICALS INC ENTA 29251M106 $35.3M 0.16% 2,418,202 SH
45 MAZE THERAPEUTICS INC MAZE 578784100 $33.1M 0.15% 1,107,814 SH
46 CG ONCOLOGY INC Call CGON 156944100 $28.4M 0.13% 400,000 SH
47 MERCK & CO INC MRK 58933Y105 $25.6M 0.12% 199,000 SH
48 WARBY PARKER INC WRBY 93403J106 $25.1M 0.12% 828,000 SH
49 PERCEPTIVE CAP SOLUTIONS COR PCSC G70077105 $24.5M 0.11% 2,250,000 SH
50 KAILERA THERAPEUTICS INC KLRA 482931102 $24.2M 0.11% 1,100,000 SH
Filing History
Period Filed AUM Holdings Accession
2026-06-30 2026-08-14 $21.68B 89 0000908834-26-000432
2026-03-31 2026-05-15 $17.54B 172 0000908834-26-000240
2026-03-31 2026-08-14 $1.52B 1 0000908834-26-000434
2025-12-31 2026-02-17 $21.19B 151 0000908834-26-000087
2025-12-31 2026-05-15 $883.7M 2 0000908834-26-000241
2025-12-31 2026-08-14 $1.03B 1 0000908834-26-000433
2025-09-30 2026-02-17 $24.43B 144 0000908834-26-000086
Filer Information
Address
ONE MARITIME PLAZA
SUITE 2100
SAN FRANCISCO, CA 94111
Phone
(415) 421-2132
Filing Manager
FARALLON CAPITAL MANAGEMENT, L.L.C.
SAN FRANCISCO, CA
Signatory
David T. Kim
Managing Member